Why the study?
Does Mocetinostat reverse cardiac fibrosis and improve cardiac function in a rat model of ischemic heart failure?
Population
Rat model of congestive heart failure secondary to myocardial infarction created by left anterior descending…
Comparison
Mocetinostat administered for 3 weeks starting 3… vs Sham hearts and untreated CHF animals/cells
Design
Preclinical
Follow-up
6 weeks post MI (3 weeks of treatment)
Authors
Loading...
Preclinical support for class I HDAC inhibition in ischemic HF; leaves open translation to human trials.
Does Mocetinostat reverse cardiac fibrosis and improve cardiac function in a rat model of ischemic heart failure?
Selective class I HDAC inhibition with Mocetinostat reverses interstitial fibrosis and improves cardiac function in a rat model of ischemic heart failure.
Nural‐Guvener et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: